Publications by authors named "Bernhard Rabold"

Claim this Profile
R
Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial.
Hartmut Goldschmidt, Elias K Mai, Jan Dürig, Christof Scheid, Katja C Weisel, Bernhard Rabold

Leukemia· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis